Document:

Exhibit
10.13

 

CUE BIOPHARMA,
INC.

2016 OMNIBUS INCENTIVE PLAN

(Formerly the Imagen Biopharma, Inc. 2016 Omnibus Incentive Plan)

 

Cue Biopharma, Inc. sets
forth herein the terms and conditions of its 2016 Omnibus Incentive Plan. The Plan was initially adopted by the Board on March
23, 2016, and initially approved by the stockholders of the Company on May 8, 2016. The Plan, as amended and restated as set forth
herein, was adopted by the Board effective August 13, 2017 (the “1st Restatement Date”), and approved by the
stockholders of the Company on [●] (the “2nd Stockholder Approval Date”).

 

1.          PURPOSE

 

The Plan is intended to
enhance the Company’s and its Affiliates’ ability to attract and retain highly qualified officers, Non-Employee Directors,
key employees and Consultants, and to motivate such officers, Non-Employee Directors, key employees and Consultants to serve the
Company and its Affiliates and to expend maximum effort to improve the business results and earnings of the Company, by providing
to such persons an opportunity to acquire or increase a direct proprietary interest in the operations and future success of the
Company. To this end, the Plan provides for the grant of stock options, restricted stock, restricted stock units, unrestricted
stock, other share-based awards and cash awards. Any of these awards may, but need not, be made as performance incentives to reward
attainment of performance goals in accordance with the terms and conditions hereof. Stock options granted under the Plan may be
non-qualified stock options or incentive stock options, as provided herein.

 

2.          DEFINITIONS

 

For purposes of interpreting
the Plan and related documents (including Award Agreements), the following definitions shall apply:

 

2.1. “Affiliate”
means any company or other trade or business that “controls,” is “controlled by” or is “under common
control” with the Company within the meaning of Rule 405 of Regulation C under the Securities Act, including any Subsidiary.

 

2.2. “Annual Incentive
Award” means a cash-based Performance Award with a performance period that is the Company’s fiscal year or other
12-month (or shorter) performance period as specified under the terms and conditions of the Award as approved by the Board.

 

2.3. “Award”
means a grant of an Option, Restricted Stock, RSU, Other Share-based Award or cash award under the Plan.

 

2.4. “Award Agreement”
means a written agreement between the Company and a Grantee, or notice from the Company or an Affiliate to a Grantee that evidences
and sets out the terms and conditions of an Award.

 

2.5. “Board”
means the Board of Directors of the Company.

 

2.6. “Business
Combination” shall have the meaning set forth in Section 14.3.2.

 

2.7. “Cause”
shall be defined as that term is defined in the Grantee’s offer letter or other applicable employment agreement; or,
if there is no such definition, “Cause” means, unless otherwise provided in the applicable Award Agreement: (i) the
commission of any act by the Grantee constituting financial dishonesty against the Company or its Affiliates (which act would be
chargeable as a crime under applicable law); (ii) the Grantee’s engaging in any other act of dishonesty, fraud, intentional
misrepresentation, moral turpitude, illegality or harassment that would (a) materially adversely affect the business or the
reputation of the Company or any of its Affiliates with their respective current or prospective customers, suppliers, lenders or
other third parties with whom such entity does or might do business or (b) expose the Company or any of its Affiliates to
a risk of civil or criminal legal damages,

 

     

     

    

 

liabilities or penalties; (iii) the repeated
failure by the Grantee to follow the directives of the Chief Executive Officer of the Company or any of its Affiliates or the Board;
or (iv) any material misconduct, violation of the Company’s or Affiliates’ policies, or willful and deliberate
non-performance of duty by the Grantee in connection with the business affairs of the Company or its Affiliates.

 

2.8. “Change in
Control” shall have the meaning set forth in Section 14.3.2.

 

2.9. “Code”
means the Internal Revenue Code of 1986.

 

2.10. “Committee”
means the Compensation Committee of the Board or any committee or other person or persons designated by the Board to administer
the Plan. The Board will cause the Committee to satisfy the applicable requirements of any securities exchange on which the Common
Stock may then be listed. For purposes of Awards to Covered Employees intended to qualify as “performance-based compensation”
under Section 162(m), to the extent required by Section 162(m), Committee means all of the members of the Committee who
are “outside directors” within the meaning of Section 162(m). For purposes of Awards to Grantees who are subject
to Section 16 of the Exchange Act, Committee means all of the members of the Committee who are “non-employee directors”
within the meaning of Rule 16b-3 adopted under the Exchange Act. All references in the Plan to the Board shall mean such Committee
or the Board to the extent the Committee has been designated by the Board to administer the Plan.

 

2.11. “Company”
means Cue Biopharma, Inc., a Delaware Corporation, or any successor corporation.

 

2.12. “Common Stock”
means the common stock of the Company.

 

2.13. “Consultant”
means a consultant or advisor that provides bona fide services to the Company or any Affiliate and who qualifies as a consultant
or advisor under Rule 701 of the Securities Act (during any period in which the Company is not a public company subject to the
reporting requirements of the Exchange Act) or Form S-8 (during any period in which the Company is a public company subject to
the reporting requirements of the Exchange Act).

 

2.14. “Corporate
Transaction” means a reorganization, merger, statutory share exchange, consolidation, sale of all or substantially all
of the Company’s assets or the acquisition of assets or stock of another entity by the Company or other corporate transaction
involving the Company or any of its Subsidiaries.

 

2.15. “Covered
Employee” means a Grantee who is a “covered employee” within the meaning of Section 162(m), as qualified
by Section 11.4.

 

2.16. “Disability”
shall be defined as that term is defined in the Grantee’s offer letter or other applicable employment agreement; or,
if there is no such definition, “Disability” means, unless otherwise provided in the applicable Award Agreement, the
Grantee is unable to perform each of the essential duties of such Grantee’s position by reason of a medically determinable
physical or mental impairment that is potentially permanent in character or that can be expected to last for a continuous period
of not less than 12 months; provided, however, that, with respect to rules regarding expiration of an Incentive Stock
Option following termination of the Grantee’s Service, “Disability” means “permanent and total disability”
as set forth in Code Section 22(e)(3).

 

2.17. “Exchange
Act” means the Securities Exchange Act of 1934.

 

2.18. “Fair Market
Value” of a Share as of a particular date means (i) if the Common Stock is listed on a national securities exchange,
the closing or last price of the Common Stock on the composite tape or other comparable reporting system for the applicable date,
or if the applicable date is not a trading day, the trading day immediately preceding the applicable date, or (ii) if the Common
Stock is not then listed on a national securities exchange, the closing or last price of the Common Stock quoted by an

 

    	 	2	 

     

    

 

established quotation service for over-the-counter
securities, or (iii) if the Common Stock is not then listed on a national securities exchange or quoted by an established quotation
service for over-the-counter securities, or the value of the Common Stock is not otherwise determinable, such value as determined
by the Board.

 

2.19. “Family Member”
means a person who is a spouse, former spouse, child, stepchild, grandchild, parent, stepparent, grandparent, niece, nephew, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother, sister, brother-in-law or sister-in-law, including adoptive relationships,
of the applicable individual, any person sharing the applicable individual’s household (other than a tenant or employee),
a trust in which any one or more of these persons have more than 50% of the beneficial interest, a foundation in which any one
or more of these persons (or the applicable individual) control the management of assets, and any other entity in which one or
more of these persons (or the applicable individual) own more than 50% of the voting interests.

 

2.20. “Grant Date”
means the latest to occur of (i) the date as of which the Board approves an Award, (ii) the date on which the recipient
of an Award first becomes eligible to receive an Award under Section 6 or (iii) such other date as may be specified
by the Board in the Award Agreement.

 

2.21. “Grantee”
means a person who receives or holds an Award.

 

2.22. “Holder”
means, with respect to any Issued Shares, the person holding such Issued Shares, including the initial Grantee or any Permitted
Transferee.

 

2.23. “Incentive
Stock Option” means an “incentive stock option” within the meaning of Code Section 422.

 

2.24. “Incumbent
Directors” shall have the meaning set forth in Section 14.3.2.

 

2.25. “Initial
Public Offering” means the initial public offering of Shares pursuant to a registration statement (other than a Form
S-8 or successor form) filed with, and declared effective by, the SEC.

 

2.26. “Issued Shares”
means, collectively, all outstanding Shares issued pursuant to Awards (including outstanding Restricted Stock prior to or after
vesting and Shares issued in connection with the exercise of an Option).

 

2.27. “Non-Employee
Director” means a member of the Board or the board of directors of an Affiliate, in each case who is not an officer or
employee of the Company or any Affiliate.

 

2.28. “Non-qualified
Stock Option” means an Option that is not an Incentive Stock Option.

 

2.29. “Offered
Shares” shall have the meaning set forth in Section 16.4.1.

 

2.30. “Offering”
shall have the meaning set forth in Section 16.5.

 

2.31. “Option”
means an option to purchase one or more Shares pursuant to the Plan.

 

2.32. “Option Price”
means the exercise price for each Share subject to an Option.

 

2.33.
“Original Effective Date” means March 23, 2016, the date the Plan was initially approved by the
Board.

 

2.34. “Other Share-based
Awards” means Awards consisting of Share units, or other Awards, valued in whole or in part by reference to, or otherwise
based on, Common Stock, other than Options, Restricted Stock and RSUs.

 

    	 	3	 

     

    

 

2.35. “Performance
Award” means an Award made subject to the attainment of performance goals (as described in Section 11) over
a performance period established by the Committee, and includes an Annual Incentive Award.

 

2.36. “Permitted
Transferee” means any of the following to whom a Holder may transfer Issued Shares hereunder (as set forth in Section
16.11.3): the Holder’s spouse, children (natural or adopted), stepchildren or a trust for their sole benefit of which
the Holder is the settlor; provided however, that any such trust does not require or permit distribution of any Issued Shares
during the term of the Plan unless subject to its terms. Upon the death of the Holder, the term Permitted Transferees shall also
include such deceased Holder’s estate, executors, administrators, personal representatives, heirs, legatees and distributees,
as the case may be.

 

2.37. “Person”
means an individual, entity or group within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act.

 

2.38. “Plan”
means this Cue Biopharma, Inc. 2016 Omnibus Incentive Plan (formerly, and originally, the Imagen Biopharma, Inc. 2016 Omnibus Incentive
Plan).

 

2.39. “Purchase
Price” means the purchase price for each Share pursuant to a grant of Restricted Stock.

 

2.40. “Restricted
Period” shall have the meaning set forth in Section 9.1.

 

2.41. “Restricted
Stock” means restricted Shares that are subject to specified terms and conditions, awarded to a Grantee pursuant to Section 9.

 

2.42. “Restricted
Stock Unit” or “RSU” means a bookkeeping entry representing the right to receive Shares or their cash
equivalent subject to the satisfaction of specified terms and conditions, awarded to a Grantee pursuant to Section 9.

 

2.43. “SEC”
means the United States Securities and Exchange Commission.

 

2.44. “Section 162(m)”
means Code Section 162(m).

 

2.45. “Section 409A”
means Code Section 409A.

 

2.46. “Securities
Act” means the Securities Act of 1933.

 

2.47. “Separation
from Service” means the termination of a Service Provider’s Service, whether initiated by the Service Provider
or the Company or an Affiliate; provided that if any Award governed by Section 409A is to be distributed on a Separation
from Service, then the definition of Separation from Service for such purposes shall comply with the definition provided in Section 409A.

 

2.48. “Service”
means service as a Service Provider to the Company or an Affiliate. Unless otherwise provided in the applicable Award Agreement,
a Grantee’s change in position or duties shall not result in interrupted or terminated Service, so long as such Grantee continues
to be a Service Provider to the Company or an Affiliate.

 

2.49. “Service
Provider” means an employee, officer, Non-Employee Director or Consultant of the Company or an Affiliate.

 

2.50. “Share”
means a share of Common Stock.

 

2.51. “Subsidiary”
means any “subsidiary corporation” of the Company within the meaning of Code Section 424(f).

 

    	 	4	 

     

    

 

2.52. “Substitute
Award” means any Award granted in assumption of or in substitution for an award of a company or business acquired by
the Company or an Affiliate or with which the Company or an Affiliate combines.

 

2.53. “Ten Percent
Stockholder” means an individual who owns more than 10% of the total combined voting power of all classes of outstanding
stock of the Company, its parent or any of its Subsidiaries. In determining stock ownership, the attribution rules of Code Section 424(d)
shall be applied.

 

2.54. “Termination
Date” means the date that is 10 years after the Original Effective Date, unless the Plan is earlier terminated by the
Board under Section 5.2.

 

2.55. “Voting Securities”
shall have the meaning set forth in Section 14.3.2.

 

3.          ADMINISTRATION
OF THE PLAN

 

3.1. General

 

The Board shall have such
powers and authorities related to the administration of the Plan as are consistent with the Company’s certificate of incorporation
and bylaws and applicable law. The Board shall have the power and authority to delegate its responsibilities hereunder to the Committee,
which shall have full authority to act in accordance with its charter, and with respect to the power and authority of the Board
to act hereunder, all references to the Board shall be deemed to include a reference to the Committee, unless such power or authority
is specifically reserved by the Board. Except as specifically provided in Section 13 or as otherwise may be required
by applicable law, regulatory requirement or the certificate of incorporation or the bylaws of the Company, the Board shall have
full power and authority to take all actions and to make all determinations required or provided for under the Plan, any Award
or any Award Agreement, and shall have full power and authority to take all such other actions and make all such other determinations
not inconsistent with the specific terms and conditions of the Plan that the Board deems to be necessary or appropriate to the
administration of the Plan. The Committee shall administer the Plan; provided that, the Board shall retain the right to
exercise the authority of the Committee to the extent consistent with applicable law and the applicable requirements of any securities
exchange on which the Common Stock may then be listed. All actions, determinations and decisions by the Board or the Committee
under the Plan, any Award or any Award Agreement shall be in the Board’s (or the Committee’s, as applicable) sole discretion
and shall be final, binding and conclusive. Without limitation, the Board shall have full and final power and authority, subject
to the other terms and conditions of the Plan, to:

 

		(i)	designate Grantees;

 

		(ii)	determine the type or types of Awards to be made to Grantees;

 

		(iii)	determine the number of Shares to be subject to an Award;

 

		(iv)	establish the terms and conditions of each Award (including
the Option Price of any Option, the nature and duration of any restriction or condition (or provision for lapse thereof) relating
to the vesting, exercise, transfer or forfeiture of an Award or the Shares subject thereto and any terms or conditions that may
be necessary to qualify Options as Incentive Stock Options);

 

		(v)	prescribe the form of each Award Agreement; and

 

		(vi)	amend, modify or supplement the terms or conditions of
any outstanding Award including the authority, in order to effectuate the purposes of the Plan, to modify Awards to foreign

 

    	 	5	 

     

    

 

nationals or individuals who are employed
outside the United States to recognize differences in local law, tax policy or custom.

 

To the extent permitted
by applicable law, the Board may delegate its authority as identified herein to any individual or committee of individuals (who
need not be directors), including the authority to make Awards to Grantees who are not subject to Section 16 of the Exchange
Act or who are not Covered Employees. To the extent that the Board delegates its authority to make Awards as provided by this Section 3.1,
all references in the Plan to the Board’s authority to make Awards and determinations with respect thereto shall be deemed
to include the Board’s delegate. Any such delegate shall serve at the pleasure of, and may be removed at any time by, the
Board.

 

3.2. Award Agreements;
Clawbacks

 

The grant of any Award may
be contingent upon the Grantee executing the appropriate Award Agreement. The Company may retain the right in an Award Agreement
to cause a forfeiture of the gain realized by a Grantee on account of actions taken by the Grantee in violation or breach of or
in conflict with any employment agreement, non-competition agreement, any agreement prohibiting solicitation of employees or clients
of the Company or any Affiliate thereof or any confidentiality obligation with respect to the Company or any Affiliate thereof,
or otherwise in competition with the Company or any Affiliate thereof, to the extent specified in such Award Agreement applicable
to the Grantee. Furthermore, the Company may annul an Award if the Grantee is terminated for Cause.

 

All Awards and any amounts
or benefits received under the Plan shall be subject to potential cancellation, recoupment, rescission, payback or other action
in accordance with the terms or conditions of any applicable Company clawback policy or any applicable law, as may be in effect
from time to time. By accepting an Award, a Grantee shall be deemed to have acknowledged and consented to the Company’s application,
implementation and enforcement of any applicable Company clawback policy that may apply to the Grantee, whether adopted prior to
or following the Award’s Grant Date, and any provision of applicable law relating to cancellation, recoupment, rescission
or payback of compensation, and to have agreed that the Company may take such actions as may be necessary to effectuate any such
policy or applicable law, without further consideration or action.

 

3.3. Deferral Arrangement

 

The Board may permit or
require the deferral of any Award payment into a deferred compensation arrangement, subject to such rules and procedures as it
may establish and in accordance with Section 409A, which may include provisions for the payment or crediting of interest or
dividend equivalents, including converting such credits into deferred Share units.

 

3.4. No Liability

 

No member of the Board or
of the Committee shall be liable for any action or determination made in good faith with respect to the Plan, any Award or Award
Agreement.

 

3.5. Book Entry

 

Notwithstanding any other
provision of the Plan to the contrary, the Company may elect to satisfy any requirement under the Plan for the delivery of stock
certificates through the use of book entry.

 

4.          STOCK
SUBJECT TO THE PLAN

 

4.1. Authorized Number
of Shares

 

Subject to adjustment under
Section 14, the aggregate number of Shares authorized to be issued under the Plan is 2,000,000, plus, effective as
of the 1st Restatement Date, 800,000 Shares (for a

 

    	 	6	 

     

    

 

total of 2,800,000 Shares as of the 1st Restatement
Date); provided, however, that on the first day of each fiscal year of the Company during the period beginning in
fiscal year 2018 and ending on the second day of fiscal year 2027, the number of Shares authorized to be issued under the Plan
shall be increased by an amount equal to the lesser of (i) the number of Shares necessary such that the aggregate number of Shares
available to be issued under the Plan equals 20.0% of the number of fully-diluted outstanding Shares on such date (assuming the
conversion of all outstanding shares of preferred stock and other outstanding convertible securities and exercise of all outstanding
options and warrants to purchase Shares) and (ii) an amount determined by the Board. Shares issued under the Plan may consist in
whole or in part of authorized but unissued Shares, treasury Shares or Shares purchased on the open market or otherwise, all as
determined by the Board from time to time.

 

4.2. Share Counting

 

4.2.1. General

 

Each Share granted in connection
with an Award shall be counted as one Share against the limit in Section 4.1, subject to the provisions of this Section 4.2.

 

4.2.2. Cash-Settled Awards

 

Any Award settled in cash
shall not be counted as issued Shares for any purpose under the Plan.

 

4.2.3. Expired or Terminated
Awards

 

If any Award expires, or is
terminated, surrendered or forfeited, in whole or in part, the unissued Shares covered by such Award shall again be available for
the grant of Awards.

 

4.2.4. Payment of Option
Price or Tax Withholding in Shares

 

If Shares issuable upon exercise,
vesting or settlement of an Award, or Shares owned by a Grantee (which are not subject to any pledge or other security interest)
are surrendered or tendered to the Company in payment of the Option Price or Purchase Price of an Award or any taxes required to
be withheld in respect of an Award, in each case, in accordance with the terms and conditions of the Plan and any applicable Award
Agreement, such surrendered or tendered Shares shall again be available for the grant of Awards.

 

4.2.5. Substitute Awards

 

Substitute Awards shall not
be counted against the number of Shares reserved under the Plan.

 

4.3. Award Limits

 

4.3.1. Incentive Stock
Options

 

Subject to adjustment under
Section 14, 2,000,000 Shares available for issuance under the Plan shall be available for issuance as Incentive Stock
Options, plus, effective as of the 1st Restatement Date, 800,000 Shares, subject to the occurrence of the 2nd Stockholder Approval
Date within 12 months after the 1st Restatement Date (for a total of 2,800,000 Shares as of the 1st Restatement Date, subject to
the occurrence of the 2nd Stockholder Approval Date within 12 months after the 1st Restatement Date).

 

    	 	7	 

     

    

 

4.3.2. Individual Award
Limits for Section 162(m) – Share-Based Awards

 

Subject to adjustment under
Section 14, the maximum number of each type of Award (other than cash-based Performance Awards) intended to qualify
as “performance-based compensation” under Section 162(m) granted to any Grantee in any calendar year shall not
exceed the following number of Shares: (i) Options: 2,000,000 Shares; and (ii) all share-based Performance Awards (including Restricted
Stock, RSUs and Other Share-based Awards that are Performance Awards): 2,000,000 Shares.

 

4.3.3. Individual Award
Limits for Section 162(m) – Cash-Based Awards

 

The maximum amount of cash-based
Performance Awards intended to constitute “performance-based compensation” under Section 162(m) granted to any
Grantee in any calendar year shall not exceed the following: (i) Annual Incentive Awards: $1.0 million; and (ii) all other cash-based
Performance Awards: $1.0 million.

 

4.3.4. Limits on Awards
to Non-Employee Directors

 

The maximum value of Awards
granted during any calendar year to any Non-Employee Director, taken together with any cash fees paid to such Non-Employee Director
during the calendar year and the value of awards granted to the Non-Employee Director under any other equity compensation plan
of the Company or an Affiliate during the calendar year, shall not exceed $250,000 (calculating the value of any Awards or other
equity compensation plan awards based on the grant date fair value for financial reporting purposes); provided, however,
that Awards granted to a Non-Employee Director upon his or her initial election to the Board or the board of directors of an Affiliate
shall not be counted towards the limit under this Section 4.3.4.

 

5.          EFFECTIVE
DATE, DURATION AND AMENDMENTS

 

5.1. Term

 

The Plan became effective
as of the Original Effective Date. The Plan shall terminate automatically on
the 10-year anniversary of the Original Effective Date and may be terminated on any earlier date as provided in Section 5.2.

 

5.2. Amendment and Termination
of the Plan

 

The Board may, at any time
and from time to time, amend, suspend or terminate the Plan as to any Awards that have not been made. An amendment shall be contingent
on approval of the Company’s stockholders to the extent stated by the Board, required by applicable law or required by applicable
securities exchange listing requirements. No Awards shall be made after the Termination Date. The applicable terms and conditions
of the Plan, and any terms and conditions applicable to Awards granted prior to the Termination Date shall survive the termination
of the Plan and continue to apply to such Awards. No amendment, suspension or termination of the Plan shall, without the consent
of the Grantee, materially impair rights or obligations under any Award theretofore awarded.

 

6.          AWARD
ELIGIBILITY AND LIMITATIONS

 

6.1. Service Providers

 

Subject to this Section 6.1,
Awards may be made to any Service Provider as the Board may determine and designate from time to time.

 

    	 	8	 

     

    

 

6.2. Successive Awards

 

An eligible person may receive
more than one Award, subject to such restrictions as are provided herein.

 

6.3. Stand-Alone, Additional,
Tandem, and Substitute Awards

 

Awards may be granted either
alone or in addition to, in tandem with or in substitution or exchange for, any other Award or any award granted under another
plan of the Company, any Affiliate or any business entity to be acquired by the Company or an Affiliate, or any other right of
a Grantee to receive payment from the Company or any Affiliate. Such additional, tandem or substitute or exchange Awards may be
granted at any time. If an Award is granted in substitution or exchange for another award, the Board shall have the right to require
the surrender of such other award in consideration for the grant of the new Award. Subject to the requirements of applicable law,
the Board may make Awards in substitution or exchange for any other award under another plan of the Company, any Affiliate or any
business entity to be acquired by the Company or an Affiliate. In addition, Awards may be granted in lieu of cash compensation,
including in lieu of cash amounts payable under other plans of the Company or any Affiliate, in which the value of Shares subject
to the Award is equivalent in value to the cash compensation (for example, RSUs or Restricted Stock).

 

7.          AWARD
AGREEMENT

 

The grant of any Award may
be contingent upon the Grantee executing an appropriate Award Agreement, in such form or forms as the Board shall from time to
time determine. Without limiting the foregoing, an Award Agreement may be provided in the form of a notice that provides that acceptance
of the Award constitutes acceptance of all terms and conditions of the Plan and the notice. Award Agreements granted from time
to time or at the same time need not contain similar provisions but shall be consistent with the terms and conditions of the Plan.
Each Award Agreement evidencing an Award of Options shall specify whether such Options are intended to be Non-qualified Stock Options
or Incentive Stock Options, and in the absence of such specification such options shall be deemed Non-qualified Stock Options.

 

8.          TERMS
AND CONDITIONS OF OPTIONS

 

8.1. Option Price

 

The Option Price of each
Option shall be fixed by the Board and stated in the related Award Agreement. The Option Price of each Option (except those that
constitute Substitute Awards) shall be at least the Fair Market Value on the Grant Date; provided, however, that
in the event that a Grantee is a Ten Percent Stockholder as of the Grant Date, the Option Price of an Option granted to such Grantee
that is intended to be an Incentive Stock Option shall be not less than 110% of the Fair Market Value on the Grant Date. In no
case shall the Option Price of any Option be less than the par value of a Share.

 

8.2. Vesting

 

Subject to Section 8.3,
each Option shall become exercisable at such times and under such conditions (including performance requirements) as stated in
the Award Agreement.

 

8.3. Term

 

Each Option shall terminate,
and all rights to purchase Shares thereunder shall cease, upon the expiration of 10 years from the Grant Date, or under such circumstances
and on such date prior thereto as is set forth in the Plan or as may be fixed by the Board and stated in the related Award Agreement;
provided, however, that in the event that the Grantee is a Ten Percent Stockholder, an Option granted to

 

    	 	9	 

     

    

 

such Grantee that is intended to be an Incentive
Stock Option at the Grant Date shall not be exercisable after the expiration of five years from its Grant Date.

 

8.4. Limitations on Exercise
of Option

 

Notwithstanding any other
provision of the Plan, in no event may any Option be exercised, in whole or in part, (i) prior to the date the Plan is approved
by the stockholders of the Company as provided herein or (ii) after the occurrence of an event that results in termination
of the Option.

 

8.5. Method of Exercise

 

An Option that is exercisable
may be exercised by the Grantee’s delivery of a notice of exercise to the Company, setting forth the number of Shares with
respect to which the Option is to be exercised, accompanied by full payment for the Shares. To be effective, notice of exercise
must be made in accordance with procedures established by the Company from time to time.

 

8.6. Rights of Holders
of Options

 

Unless otherwise provided
in the applicable Award Agreement, an individual holding or exercising an Option shall have none of the rights of a stockholder
(for example, the right to receive cash or dividend payments or distributions attributable to the subject Shares or to direct the
voting of the subject Shares) until the Shares covered thereby are fully paid and issued to him. Except as provided in Section 14
or the related Award Agreement, no adjustment shall be made for dividends, distributions or other rights for which the record date
is prior to the date of such issuance.

 

8.7. Delivery of Stock
Certificates

 

Subject to Section 3.5,
promptly after the exercise of an Option by a Grantee and the payment in full of the Option Price, such Grantee shall be entitled
to the issuance of a stock certificate or certificates evidencing his or her ownership of the Shares subject to the Option.

 

8.8. Limitations on Incentive
Stock Options

 

An Option shall constitute
an Incentive Stock Option only (i) if the Grantee of such Option is an employee of the Company or any Subsidiary of the Company,
(ii) to the extent specifically provided in the related Award Agreement and (iii) to the extent that the aggregate Fair
Market Value (determined at the time the Option is granted) with respect to which all Incentive Stock Options held by such Grantee
become exercisable for the first time during any calendar year (under the Plan and all other plans of the Grantee’s employer
and its Affiliates) does not exceed $100,000. This limitation shall be applied by taking Options into account in the order in which
they were granted.

 

9.          TERMS
AND CONDITIONS OF RESTRICTED STOCK AND RESTRICTED STOCK UNITS

 

9.1. Restrictions

 

At the time of grant, the
Board may establish a period of time (a “Restricted Period”) and any additional restrictions including the satisfaction
of corporate or individual performance objectives applicable to an Award of Restricted Stock or RSUs. Each Award of Restricted
Stock or RSUs may be subject to a different Restricted Period and additional restrictions. Neither Restricted Stock nor RSUs may
be sold, transferred, assigned, pledged or otherwise encumbered or disposed of during the Restricted Period or prior to the satisfaction
of any other applicable restrictions.

 

    	 	10	 

     

    

 

9.2. Restricted Stock
Certificates

 

The Company shall issue
Shares, in the name of each Grantee to whom Restricted Stock has been granted, stock certificates or other evidence of ownership
representing the total number of Shares of Restricted Stock granted to the Grantee, as soon as reasonably practicable after the
Grant Date. The Board may provide in an Award Agreement that either (i) the Secretary of the Company shall hold such certificates
for the Grantee’s benefit until such time as the Restricted Stock is forfeited to the Company or the restrictions lapse,
or (ii) such certificates shall be delivered to the Grantee; provided, however, that such certificates shall
bear a legend or legends that comply with the applicable securities laws and regulations and make appropriate reference to the
restrictions imposed under the Plan and the Award Agreement.

 

9.3. Rights of Holders
of Restricted Stock

 

Unless the otherwise provided
in the applicable Award Agreement and subject to Section 16.11.3, holders of Restricted Stock shall have rights as
stockholders of the Company, including voting and dividend rights.

 

9.4. Rights of Holders
of RSUs

 

9.4.1. Settlement of
RSUs

 

RSUs may be settled in cash
or Shares, as determined by the Board and set forth in the Award Agreement. The Award Agreement shall also set forth whether the
RSUs shall be settled (i) within the time period specified for “short term deferrals” under Section 409A
or (ii) otherwise within the requirements of Section 409A, in which case the Award Agreement shall specify upon which
events such RSUs shall be settled.

 

9.4.2. Voting and Dividend
Rights

 

Unless otherwise provided
in the applicable Award Agreement and subject to Section 16.11.3, holders of RSUs shall not have rights as stockholders
of the Company, including voting or dividend or dividend equivalents rights.

 

9.4.3. Creditor’s
Rights

 

A holder of RSUs shall have
no rights other than those of a general creditor of the Company. RSUs represent an unfunded and unsecured obligation of the Company,
subject to the terms and conditions of the applicable Award Agreement.

 

9.5. Purchase of Restricted
Stock

 

The Grantee shall be required,
to the extent required by applicable law, to purchase the Restricted Stock from the Company at a Purchase Price equal to the greater
of (i) the aggregate par value of the Shares represented by such Restricted Stock or (ii) the Purchase Price, if any,
specified in the related Award Agreement. If specified in the Award Agreement, the Purchase Price may be deemed paid by Services
already rendered. The Purchase Price shall be payable in a form described in Section 10 or, if so determined by the
Board, in consideration for past Services rendered.

 

9.6. Delivery of Shares

 

Upon the expiration or termination
of any Restricted Period and the satisfaction of any other conditions prescribed by the Board, the restrictions applicable to Shares
of Restricted Stock or RSUs settled in Shares shall lapse, and, unless otherwise provided in the applicable Award Agreement, a
stock

 

    	 	11	 

     

    

 

certificate for such Shares shall be delivered,
free of all such restrictions, to the Grantee or the Grantee’s beneficiary or estate, as the case may be.

 

10.        FORM
OF PAYMENT FOR OPTIONS AND RESTRICTED STOCK

 

10.1. General Rule

 

Payment of the Option Price
for the Shares purchased pursuant to the exercise of an Option or the Purchase Price for Restricted Stock shall be made in cash
or in cash equivalents acceptable to the Company, except as provided in this Section 10.

 

10.2. Surrender of Shares

 

To the extent the Award
Agreement so provides, payment of the Option Price for Shares purchased pursuant to the exercise of an Option or the Purchase Price
for Restricted Stock may be made all or in part through the tender to the Company of Shares, which Shares shall be valued, for
purposes of determining the extent to which the Option Price or Purchase Price for Restricted Stock has been paid thereby, at their
Fair Market Value on the date of exercise or surrender. Notwithstanding the foregoing, in the case of an Incentive Stock Option,
the right to make payment in the form of already-owned Shares may be authorized only at the time of grant.

 

10.3. Cashless Exercise

 

With respect to an Option
only (and not with respect to Restricted Stock), to the extent permitted by law and to the extent the Award Agreement so provides,
payment of the Option Price may be made all or in part by delivery (on a form acceptable to the Company) of an irrevocable direction
to a licensed securities broker acceptable to the Company to sell Shares and to deliver all or part of the sales proceeds to the
Company in payment of the Option Price and any withholding taxes described in Section 16.3.

 

10.4. Other Forms of
Payment

 

To the extent the Award
Agreement so provides, payment of the Option Price or the Purchase Price for Restricted Stock may be made in any other form that
is consistent with applicable laws, regulations and rules, including the Company’s withholding of Shares otherwise due to
the exercising Grantee.

 

11.        TERMS
AND CONDITIONS OF PERFORMANCE AWARDS

 

11.1. Performance Conditions

 

The right of a Grantee to
exercise or receive a grant or settlement of any Award, and the timing thereof, may be subject to such performance conditions as
may be specified by the Committee. The Committee may use such business criteria and other measures of performance as it may deem
appropriate in establishing any performance conditions.

 

11.2. Performance Awards
Granted to Designated Covered Employees

 

If and to the extent that
the Committee determines that a Performance Award to be granted to a Grantee who is designated by the Committee as likely to be
a Covered Employee should qualify as “performance-based compensation” for purposes of Section 162(m), the grant,
exercise and/or settlement of such Performance Award shall be contingent upon achievement of pre-established performance goals
and other terms and conditions set forth in this Section 11.2. Notwithstanding anything herein to the contrary, the
Committee may provide for Performance Awards to Covered Employees that are not intended to qualify as “performance-based
compensation” for purposes of Section 162(m).

 

    	 	12	 

     

    

 

11.2.1. Performance Goals
Generally

 

The performance goals for
Performance Awards shall consist of one or more business criteria and a targeted level or levels of performance with respect to
each of such criteria, as specified by the Committee consistent with this Section 11.2. Performance goals shall be
objective and shall otherwise meet the requirements of Section 162(m), including the requirement that the level or levels
of performance targeted by the Committee result in the achievement of performance goals being “substantially uncertain.”
The Committee may determine that Performance Awards shall be granted, exercised and/or settled upon achievement of any one performance
goal or that two or more of the performance goals must be achieved as a condition to grant, exercise and/or settlement of the Performance
Awards. Performance goals may be established on a Company-wide basis, or with respect to one or more business units, divisions,
Affiliates or business segments, as applicable. Performance goals may be absolute or relative (to the performance of one or more
comparable companies or indices). To the extent consistent with the requirements of Section 162(m), the Committee may determine
at the time that goals under this Section 11 are established the extent to which measurement of performance goals may
exclude the impact of charges for restructuring, discontinued operations, extraordinary items, debt redemption or retirement, asset
write downs, litigation or claim judgments or settlements, acquisitions or divestitures, foreign exchange gains and losses and
other extraordinary, unusual or non-recurring items, and the cumulative effects of tax or accounting changes (each as defined by
generally accepted accounting principles and as identified in the Company’s financial statements or other SEC filings). Performance
goals may differ for Performance Awards granted to any one Grantee or to different Grantees.

 

11.2.2. Business Criteria

 

One or more of the following
business criteria for the Company, on a consolidated basis, and/or specified Affiliates or business units of the Company (except
with respect to the total stockholder return and earnings per share criteria), shall be used exclusively by the Committee in establishing
performance goals for Performance Awards: (i) cash flow; (ii) earnings per share, as adjusted for any stock split, stock dividend
or other recapitalization; (iii) earnings measures (including EBIT and EBITDA)); (iv) return on equity; (v) total stockholder return;
(vi) share price performance, as adjusted for any stock split, stock dividend or other recapitalization; (vii) return on capital;
(viii) revenue; (ix) income; (x) profit margin; (xi) return on operating revenue; (xii) brand recognition or acceptance; (xiii)
customer metrics (including customer satisfaction, customer retention, customer profitability or customer contract terms); (xiv)
productivity; (xv) expense targets; (xvi) market share; (xvii) cost control measures; (xviii) balance sheet metrics; (xix) strategic
initiatives; (xx) implementation, completion or attainment of measurable objectives with respect to recruitment or retention of
personnel or employee satisfaction; (xxi) return on assets; (xxii) growth in net sales; (xxiii) the ratio of net sales to net working
capital; (xxiv) stockholder value added; (xxv) improvement in management of working capital items (inventory, accounts receivable
or accounts payable); (xxvi) sales from newly-introduced products; (xxvii) successful completion of, or achievement of milestones
or objectives related to, financing or capital raising transactions, strategic acquisitions or divestitures, joint ventures, partnerships,
collaborations or other transactions; (xxviii) product quality, safety, productivity, yield or reliability (on time and complete
orders); (xxix) funds from operations; (xxx) regulatory body approval for commercialization of a product; (xxxi) debt levels or
reduction or debt ratios; (xxxii) economic value; (xxxiii) operating efficiency; (xxxiv) research and development achievements;
or (xxxv) any combination of the forgoing business criteria; provided, however, that such business criteria shall
include any derivations of business criteria listed above (e.g., income shall include pre-tax income, net income and operating
income).

 

11.2.3. Timing for Establishing
Performance Goals

 

Performance goals shall be
established not later than 90 days after the beginning of any performance period applicable to Performance Awards, or at such other
date as may be required or permitted for “performance-based compensation” under Section 162(m).

 

    	 	13	 

     

    

 

11.2.4. Settlement of
Performance Awards; Other Terms

 

Settlement of Performance
Awards may be in cash, Shares, other Awards or other property, as determined by the Committee. The Committee may reduce the amount
of a settlement otherwise to be made in connection with Performance Awards.

 

11.3. Written Determinations

 

All determinations by the
Committee as to the establishment of performance goals, the amount of any Performance Award pool or potential individual Performance
Awards and as to the achievement of performance goals relating to Performance Awards, shall be made in writing in the case of any
Award intended to qualify as “performance-based compensation” under Section 162(m) to the extent required by Section 162(m).
To the extent permitted by Section 162(m), the Committee may delegate any responsibility relating to such Performance Awards.

 

11.4. Status of Section 11.2
Awards under Section 162(m)

 

It is the intent of the
Company that Performance Awards under Section 11.2 granted to persons who are designated by the Committee as likely
to be Covered Employees within the meaning of Section 162(m) shall, if so designated by the Committee, qualify as “performance-based
compensation” within the meaning of Section 162(m). Accordingly, the terms and conditions of Section 11.2,
including the definitions of Covered Employee and other terms used therein, shall be interpreted in a manner consistent with Section 162(m).
The foregoing notwithstanding, because the Committee cannot determine with certainty whether a given Grantee will be a Covered
Employee with respect to a fiscal year that has not yet been completed, the term Covered Employee as used herein shall mean only
a person designated by the Committee, at the time of grant of Performance Awards, as likely to be a Covered Employee with respect
to that fiscal year or any subsequent fiscal year. If any provision of the Plan or any agreement relating to such Performance Awards
does not comply or is inconsistent with the requirements of Section 162(m), such provision shall be construed or deemed amended
to the extent necessary to conform to such requirements.

 

12.        other
SHARE-based awards

 

12.1. Grant of Other
Share-based Awards

 

Other Share-based Awards
may be granted either alone or in addition to or in conjunction with other Awards. Other Share-based Awards may be granted in lieu
of other cash or other compensation to which a Service Provider is entitled from the Company or may be used in the settlement of
amounts payable in Shares under any other compensation plan or arrangement of the Company. Subject to the provisions of the Plan,
the Board shall have the authority to determine the persons to whom and the time or times at which such Awards will be made, the
number of Shares to be granted pursuant to such Awards, and all other terms and conditions of such Awards. Unless the Board determines
otherwise, any such Award shall be confirmed by an Award Agreement, which shall contain such provisions as the Board determines
to be necessary or appropriate to carry out the intent of the Plan with respect to such Award.

 

12.2. Terms of Other
Share-based Awards

 

Any Common Stock subject
to Awards made under this Section 12 may not be sold, assigned, transferred, pledged or otherwise encumbered prior
to the date on which the Shares are issued, or, if later, the date on which any applicable restriction, performance or deferral
period lapses.

 

    	 	14	 

     

    

 

13.        REQUIREMENTS
OF LAW

 

13.1. General

 

The Company shall not be
required to sell or issue any Shares under any Award if the sale or issuance of such Shares would constitute a violation by the
Grantee, any other individual exercising an Option or the Company of any provision of any law or regulation of any governmental
authority, including any federal or state securities laws or regulations. If at any time the Board determines that the listing,
registration or qualification of any Shares subject to an Award upon any securities exchange or under any governmental regulatory
body is necessary or desirable as a condition of, or in connection with, the issuance or purchase of Shares hereunder, no Shares
may be issued or sold to the Grantee or any other individual exercising an Option pursuant to such Award unless such listing, registration,
qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company, and
any delay caused thereby shall in no way affect the date of termination of the Award. Specifically, in connection with the Securities
Act, upon the exercise of any Option or the delivery of any Shares underlying an Award, unless a registration statement under such
Act is in effect with respect to the Shares covered by such Award, the Company shall not be required to sell or issue such Shares
unless the Board has received evidence satisfactory to it that the Grantee or any other individual exercising an Option may acquire
such Shares pursuant to an exemption from registration under the Securities Act. The Company may, but shall in no event be obligated
to, register any securities covered hereby pursuant to the Securities Act. The Company shall not be obligated to take any affirmative
action in order to cause the exercise of an Option or the issuance of Shares pursuant to the Plan to comply with any law or regulation
of any governmental authority. As to any jurisdiction that expressly imposes the requirement that an Option shall not be exercisable
until the Shares covered by such Option are registered or are exempt from registration, the exercise of such Option (under circumstances
in which the laws of such jurisdiction apply) shall be deemed conditioned upon the effectiveness of such registration or the availability
of such an exemption.

 

13.2. Section 25102(o)
of the California Corporations Code.

 

The Plan is intended to
comply with Section 25102(o) of the California Corporations Code. In that regard, to the extent required by Section 25102(o), (i)
the terms of any Options, to the extent vested and exercisable upon a Grantee’s Separation from Service, shall include any
minimum exercise periods following Separation from Service specified by Section 25102(o), and (ii) any repurchase right of the
Company with respect to Issued Shares shall include a minimum 90-day notice requirement. Any provision of the Plan that is inconsistent
with Section 25102(o) shall, without further act or amendment by the Company, be reformed to comply with the requirements of Section
25102(o).

 

13.3. Rule 16b-3

 

During any time when the
Company has a class of equity security registered under Section 12 of the Exchange Act, it is the intent of the Company that
Awards and the exercise of Options granted hereunder will qualify for the exemption provided by Rule 16b-3 under the Exchange Act.
To the extent that any provision of the Plan or action by the Board or Committee does not comply with the requirements of Rule
16b-3, it shall be deemed inoperative to the extent permitted by law and deemed advisable by the Board, and shall not affect the
validity of the Plan. In the event that Rule 16b-3 is revised or replaced, the Board may modify the Plan in any respect necessary
to satisfy the requirements of, or to take advantage of any features of, the revised exemption or its replacement.

 

14.        EFFECT
OF CHANGES IN CAPITALIZATION

 

14.1. Changes in Common
Stock

 

If (i) the number of outstanding
Shares is increased or decreased or the Shares are changed into or exchanged for a different number or kind of shares or other
securities of the Company on account of

 

    	 	15	 

     

    

 

any recapitalization, reclassification, stock
split, reverse split, combination of Shares, exchange of Shares, stock dividend or other distribution payable in capital stock,
or other increase or decrease in such Shares effected without receipt of consideration by the Company occurring after the Original
Effective Date or (ii) there occurs any spin-off, split-up, extraordinary cash dividend or other distribution of assets by the
Company, the number and kinds of shares for Awards granted (including the per-Grantee maximums set forth in Section 4)
shall be equitably adjusted by the Company; provided that any such adjustment shall comply with Section 409A. In addition,
in the event of any such increase or decease in the number of outstanding Shares or other transaction described in clause (ii)
above, the number and kind of Shares for which Awards are outstanding and the Option Price per Share of outstanding Options shall
be equitably adjusted; provided that any such adjustment shall comply with Section 409A.

 

14.2. Effect of Certain
Transactions

 

Unless otherwise provided
in the applicable Award Agreement and subject to the provisions of Section 14.3, in the event of a Corporate Transaction,
the Plan and the Awards shall continue in effect in accordance with their respective terms and conditions, except that following
a Corporate Transaction either (i) each outstanding Award shall be treated as provided for in the agreement entered into in connection
with the Corporate Transaction or (ii) if not so provided in such agreement, each Grantee shall be entitled to receive in respect
of each Share subject to any outstanding Awards, upon exercise or payment or transfer in respect of any Award, the same number
and kind of stock, securities, cash, property or other consideration that each holder of a Share was entitled to receive in the
Corporate Transaction in respect of a Share; provided, however, that, unless otherwise determined by the Board, such
stock, securities, cash, property or other consideration shall remain subject to all of the conditions, restrictions and performance
criteria that were applicable to the Awards prior to such Corporate Transaction. Without limiting the generality of the foregoing,
the treatment of outstanding Options pursuant to this Section 14.2 in connection with a Corporate Transaction in which
the consideration paid or distributed to the Company’s stockholders is not entirely shares of common stock of the acquiring
or resulting corporation may include the cancellation of outstanding Options upon consummation of the Corporate Transaction as
long as, at the election of the Board, (i) the holders of affected Options have been given a period of at least 15 days prior to
the date of the consummation of the Corporate Transaction to exercise the Options (to the extent otherwise exercisable) or (ii)
the holders of the affected Options are paid (in cash or cash equivalents) in respect of each Share covered by the Option being
canceled an amount equal to the excess, if any, of the per Share price paid or distributed to stockholders in the Corporate Transaction
(the value of any non-cash consideration to be determined by the Board) over the Option Price. For avoidance of doubt, (1) the
cancellation of Options pursuant to clause (ii) of the preceding sentence may be effected notwithstanding anything to the contrary
contained in the Plan or any Award Agreement and (2) if the amount determined pursuant to clause (ii) of the preceding sentence
is zero or less, the affected Option may be cancelled without any payment therefore. The treatment of any Award as provided in
this Section 14.2 shall be conclusively presumed to be appropriate for purposes of Section 14.1.

 

14.3. Change in Control

 

14.3.1. Consequences
of a Change in Control

 

For Awards granted to Non-Employee
Directors, unless otherwise provided in the applicable Award Agreement, upon a Change in Control all such outstanding Awards that
may be exercised shall become fully exercisable, all restrictions with respect to such outstanding Awards shall lapse and become
vested and non-forfeitable, and any specified performance goals with respect to outstanding Awards shall be deemed to be satisfied
at target.

 

For Awards granted to any
other Service Providers, unless otherwise provided in the applicable Award Agreement, either of the following provisions shall
apply, depending on whether, and the extent to which, such Awards are assumed, converted or replaced by the resulting entity in
a Change in Control:

 

    	 	16	 

     

    

 

		(i)	To the extent such Awards are not assumed, converted or
replaced by the resulting entity in the Change in Control, then upon the Change in Control such outstanding Awards that may be
exercised shall become fully exercisable, all restrictions with respect to such outstanding Awards, other than for Performance
Awards, shall lapse and become vested and non-forfeitable, and for any outstanding Performance Awards the target payout opportunities
attainable under such Awards shall be deemed to have been fully earned as of the Change in Control based upon the greater of (A)
an assumed achievement of all relevant performance goals at the “target” level or (B) the actual level of achievement
of all relevant performance goals against target as of the Company’s fiscal quarter end preceding the Change in Control
and the Award shall become vested pro rata based on the portion of the applicable performance period completed through the date
of the Change in Control.

 

		(ii)	To the extent such Awards are assumed, converted or replaced
by the resulting entity in the Change in Control, if, within two years after the date of the Change in Control, the Service Provider
has a Separation from Service either (1) by the Company other than for Cause or (2) by the Service Provider for “good reason”
(as defined in the applicable Award Agreement), then such outstanding Awards that may be exercised shall become fully exercisable,
all restrictions with respect to such outstanding Awards, other than for Performance Awards, shall lapse and become vested and
non-forfeitable, and for any outstanding Performance Awards the target payout opportunities attainable under such Awards shall
be deemed to have been fully earned as of the Separation from Service based upon the greater of (A) an assumed achievement of
all relevant performance goals at the “target” level or (B) the actual level of achievement of all relevant performance
goals against target as of the Company’s fiscal quarter end preceding the Change in Control and the Award shall become vested
pro rata based on the portion of the applicable performance period completed through the date of the Separation from Service.

 

14.3.2. Change in Control
Defined

 

Unless otherwise provided
in the applicable Award Agreement, a “Change in Control” means the consummation of any of the following events:

 

		(i)	The acquisition, other than from the Company, by any individual,
entity or group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act), other than the Company
or any subsidiary, affiliate (within the meaning of Rule 144 promulgated under the Securities Act) or employee benefit plan of
the Company, of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than 50% of
the combined voting power of the then outstanding voting securities of the Company entitled to vote generally in the election
of directors (the “Voting Securities”); or

 

		(ii)	A reorganization, merger, consolidation or recapitalization
of the Company (a “Business Combination”), other than a Business Combination in which more than 50% of the
combined voting power of the outstanding voting securities of the surviving or resulting entity immediately following the Business
Combination is held by the Persons who, immediately prior to the Business Combination, were the holders of the Voting Securities;
or

 

		(iii)	A complete liquidation or dissolution of the Company, or
a sale of all or substantially all of the assets of the Company; or

 

    	 	17	 

     

    

 

		(iv)	During any period of 24 consecutive months, the Incumbent
Directors cease to constitute a majority of the Board; “Incumbent Directors” means individuals who were members
of the Board at the beginning of such period or individuals whose election or nomination for election to the Board by the Stockholders
was approved by a vote of at least a majority of the then Incumbent Directors (but excluding any individual whose initial election
or nomination is in connection with an actual or threatened proxy contest relating to the election of directors).

 

Notwithstanding the foregoing,
if it is determined that an Award is subject to the requirements of Section 409A and payable upon a Change in Control, the
Company will not be deemed to have undergone a Change in Control for purposes of the Plan unless the Company is deemed to have
undergone a “change in control event” pursuant to the definition of such term in Section 409A.

 

14.4. Adjustments

 

Adjustments under this Section 14
related to Shares or securities of the Company shall be made by the Board. No fractional Shares or other securities shall be issued
pursuant to any such adjustment, and any fractions resulting from any such adjustment shall be eliminated in each case by rounding
downward to the nearest whole Share.

 

15.        No
Limitations on Company

 

The making of Awards shall
not affect or limit in any way the right or power of the Company to make adjustments, reclassifications, reorganizations or changes
of its capital or business structure or to merge, consolidate, dissolve or liquidate, or to sell or transfer all or any part of
its business or assets.

 

16.        TERMS
APPLICABLE GENERALLY TO AWARDS

 

16.1. Disclaimer of Rights

 

No provision in the Plan
or in any Award Agreement shall be construed to confer upon any individual the right to remain in the employ or service of the
Company or any Affiliate, or to interfere in any way with any contractual or other right or authority of the Company or any Affiliate
either to increase or decrease the compensation or other payments to any individual at any time, or to terminate any employment
or other relationship between any individual and the Company or any Affiliate. In addition, notwithstanding anything contained
in the Plan to the contrary, unless otherwise provided in the applicable Award Agreement, no Award shall be affected by any change
of duties or position of the Grantee, so long as such Grantee continues to be a Service Provider. The obligation of the Company
to pay any benefits pursuant to the Plan shall be interpreted as a contractual obligation to pay only those amounts described herein,
in the manner and under the conditions prescribed herein. The Plan shall in no way be interpreted to require the Company to transfer
any amounts to a third party trustee or otherwise hold any amounts in trust or escrow for payment to any Grantee or beneficiary
under the terms and conditions of the Plan.

 

16.2. Nonexclusivity
of the Plan

 

Neither the adoption of
the Plan nor the submission of the Plan to the stockholders of the Company for approval shall be construed as creating any limitations
upon the right and authority of the Board or its delegate to adopt such other compensation arrangements as the Board or its delegate
determines desirable.

 

16.3. Withholding Taxes

 

The Company or an Affiliate,
as the case may be, shall have the right to deduct from payments of any kind otherwise due to a Grantee any federal, state or local
taxes of any kind required by law to be

 

    	 	18	 

     

    

 

withheld (i) with respect to the vesting
of or other lapse of restrictions applicable to an Award, (ii) upon the issuance of any Shares upon the exercise of an Option
or (iii) otherwise due in connection with an Award. At the time of such vesting, lapse or exercise, the Grantee shall pay
to the Company or the Affiliate, as the case may be, any amount that the Company or the Affiliate may reasonably determine to be
necessary to satisfy such withholding obligation. Subject to the prior approval of the Board, the Grantee may elect to satisfy
such obligations, or the Company may require such obligations to be satisfied, in whole or in part, (i) by causing the Company
or the Affiliate to withhold the minimum required number of Shares otherwise issuable to the Grantee as may be necessary to satisfy
such withholding obligation or (ii) by delivering to the Company or the Affiliate Shares already owned by the Grantee. The
Shares so delivered or withheld shall have an aggregate Fair Market Value equal to such withholding obligations. The Fair Market
Value used to satisfy such withholding obligation shall be determined by the Company or the Affiliate as of the date that the amount
of tax to be withheld is to be determined. A Grantee who has made an election pursuant to this Section 16.3 may satisfy
his or her withholding obligation only with Shares that are not subject to any repurchase, forfeiture, unfulfilled vesting or other
similar requirements.

 

16.4. Right of First
Refusal; Right of Repurchase.

 

16.4.1. Right of First
Refusal.

 

Unless otherwise provided
in the applicable Award Agreement, stockholders’ agreement or other agreement to which a Holder is a party, at any time prior
to registration by the Company of its Common Stock under Section 12 of the Exchange Act, in the event that the Holder desires at
any time to sell or otherwise transfer all or any part of such Holder’s Issued Shares (to the extent vested), the Holder
first shall give written notice to the Company of the Holder’s intention to make such transfer. Such notice shall state the
number of Issued Shares that the Holder proposes to sell (the “Offered Shares”), the price and the terms at
which the proposed sale is to be made and the name and address of the proposed transferee. At any time within 30 days after the
receipt of such notice by the Company, the Company or its assigns may elect to purchase all or any portion of the Offered Shares
at the price and on the terms offered by the proposed transferee and specified in the notice. The Company or its assigns shall
exercise this right by mailing or delivering written notice to the Holder within the foregoing 30-day period. If the Company or
its assigns elect to exercise its purchase rights under this Section 16.4.1, the closing for such purchase shall, in any
event, take place within 45 days after the receipt by the Company of the initial notice from the Holder. In the event that the
Company or its assigns do not elect to exercise such purchase right, or in the event that the Company or its assigns do not pay
the full purchase price within such 45-day period, the Holder may, within 60 days thereafter, sell the Offered Shares to the proposed
transferee at the same price and on the same terms as specified in the Holder’s notice. Any Issued Shares purchased by such
proposed transferee shall remain subject to the Plan.

 

16.4.2. Right of Repurchase.

 

Unless otherwise provided
in the applicable Award Agreement, stockholders’ agreement or other agreement to which a Grantee is a party, at any time
prior to registration by the Company of its Common Stock under Section 12 of the Exchange Act, in the case of any Grantee whose
Separation from Service is for Cause, or where the Grantee has, as determined by the Board, taken any action prior to or following
the Grantee’s Separation of Service that would have constituted grounds for Cause, the Company shall have the right, exercisable
at any time and from time to time thereafter, to repurchase from the Grantee (or any successor in interest by purchase, gift or
other mode of transfer) any Shares issued to the Grantee under the Plan for the purchase price paid by the Grantee for such Shares
(or the Fair Market Value of the Shares at the time of repurchase, if lower).

 

16.5. Market Standoff
Requirement.

 

Unless otherwise provided
in the applicable Award Agreement, stockholders’ agreement or other agreement to which a Grantee is a party, in connection
with any underwritten public offering of its Common Stock (“Offering”) and upon request of the Company or the
underwriters managing the Offering, Grantees shall not be permitted to sell, make any short sale of, loan, grant any option for
the purchase of

 

    	 	19	 

     

    

 

or otherwise directly or indirectly dispose
of any Common Stock delivered under the Plan (other than those Shares included in the Offering) without the prior written consent
of the Company or such underwriters, as the case may be, for such period of time from the effective date of the registration statement
with respect to such Offering as may be requested by the Company or such managing underwriters and to execute an agreement reflecting
the foregoing as may be requested by the underwriters in connection with such Offering.

 

16.6. Other Provisions

 

Each Award Agreement may
contain such other terms and conditions not inconsistent with the Plan as may be determined by the Board. In the event of any conflict
between the terms and conditions of an employment agreement and the Plan, the terms and conditions of the employment agreement
shall govern.

 

16.7. Severability

 

If any provision of the
Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court of law in any jurisdiction, the remaining
provisions hereof and thereof shall be severable and enforceable in accordance with their terms and conditions, and all provisions
shall remain enforceable in any other jurisdiction.

 

16.8. Governing Law

 

The Plan shall be governed
by and construed in accordance with the laws of the State of Delaware without giving effect to the principles of conflicts of law,
and applicable Federal law.

 

16.9. Section 409A

 

The Plan is intended to
comply with Section 409A to the extent subject thereto, and, accordingly, to the maximum extent permitted, the Plan shall
be interpreted and administered to be in compliance therewith. Any payments described in the Plan that are due within the “short-term
deferral period” as defined in Section 409A shall not be treated as deferred compensation unless applicable laws require
otherwise. Notwithstanding anything to the contrary in the Plan, to the extent required to avoid accelerated taxation and tax penalties
under Section 409A, amounts that would otherwise be payable and benefits that would otherwise be provided pursuant to the
Plan during the six-month period immediately following the Grantee’s Separation from Service shall instead be paid on the
first payroll date after the six-month anniversary of the Grantee’s Separation from Service (or the Grantee’s death,
if earlier). Notwithstanding the foregoing, neither the Company nor the Board shall have any obligation to take any action to prevent
the assessment of any excise tax or penalty on any Grantee under Section 409A and neither the Company nor the Board shall
have any liability to any Grantee for such tax or penalty.

 

16.10. Separation from
Service

 

The Board shall determine
the effect of a Separation from Service upon Awards, and such effect shall be set forth in the applicable Award Agreement. Without
limiting the foregoing, the Board may provide in the Award Agreements at the time of grant, or any time thereafter with the consent
of the Grantee, the actions that will be taken upon the occurrence of a Separation from Service, including accelerated vesting
or termination, depending upon the circumstances surrounding the Separation from Service.

 

    	 	20	 

     

    

 

16.11. Transferability
of Awards

 

16.11.1. Transfers in
General

 

Except as provided in Section 16.11.2,
no Award shall be assignable or transferable by the Grantee to whom it is granted, other than by will or the laws of descent and
distribution, and, during the lifetime of the Grantee, only the Grantee personally (or the Grantee’s personal representative)
may exercise rights under the Plan.

 

16.11.2. Family Transfers

 

If authorized in the applicable
Award Agreement, a Grantee may transfer, not for value, all or part of an Award (other than Incentive Stock Options) to any Family
Member. For the purpose of this Section 16.11.2, a “not for value” transfer is a transfer that is (i) a
gift, (ii) a transfer under a domestic relations order in settlement of marital property rights or (iii) a transfer to
an entity in which more than 50% of the voting interests are owned by Family Members (or the Grantee) in exchange for an interest
in that entity. Following a transfer under this Section 16.11.2, any such Award shall continue to be subject to the
same terms and conditions as were applicable immediately prior to transfer. Subsequent transfers of transferred Awards are prohibited
except to Family Members of the original Grantee in accordance with this Section 16.11.2 or by will or the laws of
descent and distribution.

 

16.11.3. Issued Shares

 

No Issued Shares shall be
sold, assigned, transferred, pledged, hypothecated, given away or in any other manner disposed of or encumbered, whether voluntarily
or by operation of law, unless (i) such transfer is in compliance with the terms of the applicable Award, all applicable securities
laws, and the terms and conditions of the Plan (including Sections 16.4 and 16.5 and this Section 16.11.3),
(ii) such transfer does not cause the Company to become subject to the reporting requirements of the Exchange Act and (iii) the
transferee consents in writing to be bound by the provisions of the Plan (including Sections 16.4 and 16.5 and this
Section 16.11.3). In connection with any proposed transfer, the Board may require the transferor to provide at the transferor’s
own expense an opinion of counsel to the transferor, satisfactory to the Board, that such transfer is in compliance with all foreign,
federal and state securities laws. Any attempted disposition of Issued Shares not in accordance with the terms and conditions of
this Section 16.11.3 shall be null and void, and the Company shall not reflect on its records any change in record ownership
of any Issued Shares as a result of any such disposition, shall otherwise refuse to recognize any such disposition and shall not
in any way give effect to any such disposition of Issued Shares. Subject to the foregoing general provisions, and unless otherwise
provided in the agreement with respect to a particular Award, Issued Shares may be transferred pursuant to the following specific
terms and conditions:

 

The Holder may sell, assign,
transfer or give away any or all of the Issued Shares to Permitted Transferees; provided, however, that following
such sale, assignment or other transfer, such Issued Shares shall continue to be subject to the terms of the Plan (including Sections
16.4 and 16.5 and this Section 16.11.3) and such Permitted Transferee(s) shall, as a condition to any such transfer,
deliver a written acknowledgment to that effect to the Company.

 

Upon the death of the Holder,
any Issued Shares then held by the Holder at the time of such death and any Issued Shares acquired thereafter by the Holder’s
legal representative shall be subject to the provisions of the Plan, and the Holder’s estate, executors, administrators,
personal representatives, heirs, legatees and distributees shall be obligated to convey such Issued Shares to the Company or its
assigns under the terms contemplated hereby.

 

    	 	21	 

     

    

 

16.12. Dividends and
Dividend Equivalent Rights

 

If specified in the Award
Agreement, the recipient of an Award may be entitled to receive, currently or on a deferred basis, dividends or dividend equivalents
with respect to the Common Stock or other securities covered by an Award. The terms and conditions of a dividend equivalent right
may be set forth in the Award Agreement. Dividend equivalents credited to a Grantee may be paid currently or may be deemed to be
reinvested in additional Shares or other securities of the Company at a price per unit equal to the Fair Market Value on the date
that such dividend was paid to stockholders, as determined by the Board. Notwithstanding the foregoing, in no event will dividends
or dividend equivalents on any Award that is subject to the achievement of performance criteria be payable before the Award has
become earned and payable.

 

16.13. Plan Construction

 

In the Plan, unless otherwise
stated, the following uses apply: (i) references to a statute or law refer to the statute or law and any amendments and any
successor statutes or laws, and to all valid and binding governmental regulations, court decisions and other regulatory and judicial
authority issued or rendered thereunder, as amended, or their successors, as in effect at the relevant time; (ii) in computing
periods from a specified date to a later specified date, the words “from” and “commencing on” (and the
like) mean “from and including,” and the words “to,” “until” and “ending on” (and
the like) mean “to and including”; (iii) indications of time of day shall be based upon the time applicable to
the location of the principal headquarters of the Company; (iv) the words “include,” “includes” and
“including” (and the like) mean “include, without limitation,” “includes, without limitation”
and “including, without limitation” (and the like), respectively; (v) all references to articles and sections
are to articles and sections in the Plan; (vi) all words used shall be construed to be of such gender or number as the circumstances
and context require; (vii) the captions and headings of articles and sections have been inserted solely for convenience of
reference and shall not be considered a part of the Plan, nor shall any of them affect the meaning or interpretation of the Plan
or any of its provisions; (viii) any reference to an agreement, plan, policy, form, document or set of documents, and the
rights and obligations of the parties under any such agreement, plan, policy, form, document or set of documents, shall mean such
agreement, plan, policy, form, document or set of documents as amended from time to time, and any and all modifications, extensions,
renewals, substitutions or replacements thereof; and (ix) all accounting terms not specifically defined shall be construed
in accordance with generally accepted accounting principles.

 

    	 	22Exhibit
10.14

 

NOTICE OF GRANT OF [INCENTIVE/NON-QUALIFIED]
STOCK OPTION

 

IMAGEN BIOPHARMA, INC.

[2016 OMNIBUS INCENTIVE PLAN] [2016 NON-EMPLOYEE EQUITY INCENTIVE PLAN]

 

FOR GOOD AND VALUABLE CONSIDERATION, Imagen Biopharma,
Inc. (the “Company”) hereby grants, pursuant to the provisions of the [Imagen Biopharma, Inc. 2016 Omnibus Incentive
Plan] [Imagen Biopharma, Inc. 2016 Non-Employee Equity Incentive Plan ] (the “Plan”), to the Grantee designated
in this Notice of Grant of [Incentive/Non-qualified] Stock Option (the “Notice of Grant”) [an Incentive/a Non-qualified]
Stock Option to purchase the number of Shares set forth in the Notice of Grant (the “Option”), subject to certain
terms and conditions as outlined below in the Notice of Grant and the additional terms and conditions set forth in the attached
Terms and Conditions of Stock Option (together with the Notice of Grant, the “Award Agreement”).

 

	Grantee:	[Name]
	Type of Option:	[Incentive/Non-qualified] Stock Option
	Grant Date:	[Date]
	Number of Shares Purchasable:	[####]
	Option Price per Share:	$[#.##], which is the Fair Market Value as of the Grant Date
	Expiration Date:	[Date], which is [●] years from the Grant Date
	Exercisability Schedule:	
        [Insert schedule – time-based or performance-based] 

	Exercise after Separation from Service:	
        Separation from Service for any reason other than death, Disability
        or Cause: any non-exercisable portion of the Option expires immediately and any exercisable portion of the Option remains exercisable
        for 90 days following Separation from Service for any reason other than death, Disability or Cause;

         

        Separation from Service due to death or Disability: any non-exercisable
        portion of the Option expires immediately and any exercisable portion of the Option remains exercisable for 12 months following
        Separation from Service due to death or Disability; and

         

        Separation from Service for Cause: the entire Option, including
        any exercisable and non-exercisable portion, expires immediately upon Separation from Service for Cause.

         

        In no event may THE Option
        be exercised after the Expiration Date as provided above.

 

    	 	Notice of Grant - Page 1
	 

     

    

 

By signing below, the Grantee agrees that the Option is granted under
and governed by the terms and conditions of the Plan and the Award Agreement, as of the Grant Date.

 

	GRANTEE	 	IMAGEN BIOPHARMA, INC.
	 	 	 	 	 	 
	Sign Name:		 	Sign Name:		 
	 	 	 	 	 	 
	Print Name:		 	Print Name:		 
	 	 	 	 	 	 
	 	 	 	Title:		 

 

    	 	Notice of Grant - Page 2
	 

     

    

 

TERMS AND
CONDITIONS OF STOCK OPTION

 

1.         Grant
of Option. The Option granted to the Grantee and described in the Notice of Grant is subject to the terms and conditions of
the Plan. The terms and conditions of the Plan are hereby incorporated herein by reference. Except as otherwise expressly set forth
herein, the Award Agreement shall be construed in accordance with the terms and conditions of the Plan. Any capitalized term not
otherwise defined in the Award Agreement shall have the definition set forth in the Plan.

 

The Committee has approved the grant to the Grantee
of the Option, conditioned upon the Grantee’s acceptance of the terms and conditions of the Award Agreement within 60 days
after the Award Agreement is presented to the Grantee for review.

 

[If designated in the Notice of Grant as an Incentive
Stock Option, the Option is intended to qualify as an Incentive Stock Option. To the extent that the Option fails to meet the requirements
of an Incentive Stock Option or is not designated as an Incentive Stock Option, the Option shall be treated as a Non-qualified
Stock Option.]

 

2.         Exercise
of Option.

 

(a)       Right
to Exercise. The Option shall be exercisable, in whole or in part, during its term in accordance with the Exercisability Schedule
set forth in the Notice of Grant and with the applicable provisions of the Plan and the Award Agreement. No Shares shall be issued
pursuant to the exercise of the Option unless the issuance and exercise comply with applicable laws. Assuming such compliance,
for income tax purposes the Shares shall be considered transferred to the Grantee on the date on which the Option is exercised
with respect to such Shares. Until such time as the Option has been duly exercised and Shares have been delivered, the Grantee
shall not be entitled to exercise any voting rights with respect to such Shares, shall not be entitled to receive dividends or
other distributions with respect thereto and shall not have any other rights of a stockholder with respect thereto.

 

(b)       Method
of Exercise. The Grantee may exercise the Option by delivering an exercise notice in a form approved by the Company (the “Exercise
Notice”), which shall state the election to exercise the Option, the number of Shares with respect to which the Option
is being exercised, and such other representations and agreements as may be required by the Company. The Exercise Notice shall
be accompanied by payment of the aggregate Option Price as to all Shares exercised. The Option shall be deemed to be exercised
upon receipt by the Company of such fully executed Exercise Notice accompanied by the aggregate Option Price (as well as any applicable
withholding or other taxes).

 

(c)       Acceleration
of Exercisability under Certain Circumstances. The exercisability of the Option shall not be accelerated under any circumstances,
except as otherwise provided in the Plan.

 

3.         Method
of Payment. If the Grantee elects to exercise the Option by submitting an Exercise Notice in accordance with Section 2(b)
above, the aggregate Option Price (as well as any applicable withholding or other taxes) shall be paid by cash or check; provided,
however, that the Committee may, but is not required to, consent to payment in any of the following forms, or a combination
of them:

 

(a)       cash
or check;

 

(b)       a
“net exercise” under which the Company reduces the number of Shares issued upon exercise by the largest whole number
of Shares with a Fair Market Value that does not exceed the aggregate Option Price and any applicable withholding, or such other
consideration received by the Company under a cashless exercise program approved by the Company in connection with the Plan;

 

(c)       surrender
of other Shares owned by the Grantee that have a Fair Market Value on the date of surrender equal to the aggregate Option Price
of the exercised Shares and any applicable withholding; or

 

    	 	Terms and Conditions - Page 1
	 

     

    

 

(d)       any
other consideration that the Committee deems appropriate and in compliance with applicable law.

 

4.         Restrictions
on Exercise. The Option may not be exercised until such time as the Plan has been approved by the stockholders of the Company,
or if the issuance of the Shares upon exercise or the method of payment of consideration for those Shares would constitute a violation
of any applicable law, regulation or Company policy.

 

5.         Transferability.

 

(a)       The
Option may not be transferred in any manner other than by will or by the laws of descent or distribution and may be exercised during
the lifetime of the Grantee only by the Grantee; provided, however, that the Grantee may transfer the Option (a)
pursuant to a domestic relations order by a court of competent jurisdiction or (b) to any Family Member of the Grantee in accordance
with Section 17.11.2 of the Plan by delivering to the Company a notice of assignment in a form acceptable to the Company.
No transfer or assignment of the Option to or on behalf of a Family Member under this Section 5 shall be effective until the
Company has acknowledged such transfer or assignment in writing.

 

(b)       Without
limitation of Section 9 below, any Issued Shares in connection with the Option shall be subject to the Company’s right of
first refusal under Section 17.4.1 of the Plan, the Company’s right of repurchase under Section 17.4.2 of the Plan, the market
standoff requirement under Section 17.5 of the Plan, and the transfer restrictions under Section 17.11.3 of the Plan.

 

6.         Term
of Option. The Option may be exercised only within the term set forth in the Notice of Grant, and may be exercised during such
term only in accordance with the Plan and the terms of the Award Agreement.

 

7.         Withholding.

 

(a)       The
Committee shall determine the amount of any withholding or other tax required by law to be withheld or paid by the Company with
respect to any income recognized by the Grantee with respect to the Option.

 

(b)       The
Grantee shall be required to meet any applicable tax withholding obligation in accordance with the provisions of Section 17.3
of the Plan.

 

[(c)       If
the Grantee makes any disposition of Shares delivered pursuant to the exercise of an Incentive Stock Option under the circumstances
described in Code Section 421(b) (relating to certain disqualifying dispositions), the Grantee shall notify the Company of such
disposition within 10 days of such disposition.]

 

8.         Adjustment.
Upon any event described in Section 15 of the Plan occurring after the Grant Date, the adjustment provisions as provided for
under Section 15 of the Plan shall apply to the Option.

 

9.         Bound
by Plan and Committee Decisions. By accepting the Option, the Grantee acknowledges that the Grantee has received a copy of
the Plan, has had an opportunity to review the Plan, and agrees to be bound by all of the terms and conditions of the Plan. In
the event of any conflict between the provisions of the Award Agreement and the Plan, the provisions of the Plan shall control.
The authority to manage and control the operation and administration of the Award Agreement and the Plan shall be vested in the
Committee, and the Committee shall have all powers with respect to the Award Agreement as it has with respect to the Plan. Any
interpretation of the Award Agreement or the Plan by the Committee and any decision made by the Committee with respect to the Award
Agreement or the Plan shall be final and binding on all persons.

 

10.        Grantee
Representations. The Grantee hereby represents to the Company that the Grantee has read and fully understands the provisions
of the Award Agreement and the Plan and that the Grantee’s decision

 

    	 	Terms and Conditions - Page 2
	 

     

    

 

to participate in the Plan is completely voluntary. Further, the
Grantee acknowledges that the Grantee is relying solely on his or her own advisors with respect to the tax consequences of the
Option.

 

11.       Regulatory
Limitations on Exercises. Notwithstanding the other provisions of the Award Agreement, the Committee may impose such conditions,
restrictions and limitations (including suspending the exercise of the Option and the tolling of any applicable exercise period
during such suspension) on the issuance of Common Stock with respect to the Option unless and until the Committee determines that
such issuance complies with (a) any applicable registration requirements under the Securities Act or the Committee has determined
that an exemption therefrom is available, (b) any applicable listing requirement of any stock exchange on which the Common Stock
is listed, (c) any applicable Company policy or administrative rules and (d) any other applicable provision of state, federal or
foreign law, including foreign securities laws where applicable.

 

12.       Miscellaneous.

 

(a)       Notices.
Any notice that either party hereto may be required or permitted to give to the other shall be in writing and may be delivered
personally, by intraoffice mail, by fax, by electronic mail or other electronic means, or via a postal service, postage prepaid,
to such electronic mail or postal address and directed to such person as the Company may notify the Grantee from time to time;
and to the Grantee at the Grantee’s electronic mail or postal address as shown on the records of the Company from time to
time, or at such other electronic mail or postal address as the Grantee, by notice to the Company, may designate in writing from
time to time.

 

(b)       Waiver.
The waiver by any party hereto of a breach of any provision of the Award Agreement shall not operate or be construed as a waiver
of any other or subsequent breach.

 

(c)       Entire
Agreement. The Award Agreement and the Plan constitute the entire agreement between the parties with respect to the Option.
Any prior agreements, commitments or negotiations concerning the Option are superseded.

 

(d)       Binding
Effect; Successors. The obligations and rights of the Company under the Award Agreement shall be binding upon and inure to
the benefit of the Company and any successor corporation or organization resulting from the merger, consolidation, sale, or other
reorganization of the Company, or upon any successor corporation or organization succeeding to substantially all of the assets
and business of the Company. The obligations and rights of the Grantee under the Award Agreement shall be binding upon and inure
to the benefit of the Grantee and the beneficiaries, executors, administrators, heirs and successors of the Grantee.

 

(e)       Governing
Law; Consent to Jurisdiction; Consent to Venue. The Award Agreement shall be construed and interpreted in accordance with the
internal laws of the State of Delaware without regard to principles of conflicts of law thereof, or principles of conflicts of
laws of any other jurisdiction that could cause the application of the laws of any jurisdiction other than the State of Delaware.
For purposes of resolving any dispute that arises directly or indirectly from the relationship of the parties evidenced by the
Option or the Award Agreement, the parties hereto hereby submit to and consent to the exclusive jurisdiction of the State of Massachusetts
and agree that any related litigation shall be conducted solely in the courts of Suffolk County, Massachusetts or the federal courts
for the United States for the District of Massachusetts, where the Award Agreement is made and/or to be performed, and no other
courts.

 

(f)        Headings.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the
meaning or interpretation of any of the terms or provisions of the Award Agreement.

 

(g)       Amendment.
The Award Agreement may be amended at any time by the Committee, provided that no amendment may, without the consent of
the Grantee, materially impair the Grantee’s rights with respect to the Option.

 

    	 	Terms and Conditions - Page 3
	 

     

    

 

(h)       Severability.
The invalidity or unenforceability of any provision of the Award Agreement shall not affect the validity or enforceability of any
other provision of the Award Agreement, and each other provision of the Award Agreement shall be severable and enforceable to the
extent permitted by law.

 

(i)        No
Rights to Service. Nothing contained in the Award Agreement shall be construed as giving the Grantee any right to be retained,
in any position, as a director, officer, employee, or consultant of the Company or its Affiliates, or shall interfere with or restrict
in any way the rights of the Company or its Affiliates, which are hereby expressly reserved, to remove, terminate or discharge
the Grantee at any time for any reason whatsoever or for no reason, subject to the Company’s articles of incorporation, bylaws
and other similar governing documents and applicable law.

 

(j)        Section
409A. It is intended that the Award Agreement and the Option will be exempt from (or in the alternative will comply with) Code
Section 409A, and the Award Agreement shall be administered accordingly and interpreted and construed on a basis consistent with
such intent. This Section 12(j) shall not be construed as a guarantee of any particular tax effect for the Grantee’s
benefits under the Award Agreement and the Company does not guarantee that any such benefits will satisfy the provisions of Code
Section 409A or any other provision of the Code.

 

(j)        Further
Assurances. The Grantee agrees, upon demand of the Company or the Committee, to do all acts and execute, deliver and perform
all additional documents, instruments and agreements that may be reasonably required by the Company or the Committee, as the case
may be, to implement the provisions and purposes of the Award Agreement and the Plan.

 

(k)       Confidentiality.
The Grantee agrees that the terms and conditions of the Option award reflected in the Award Agreement are strictly confidential
and, with the exception of the Grantee’s counsel, tax advisor, immediate family, or as required by applicable law, have not
and shall not be disclosed, discussed or revealed to any other persons, entities or organizations, whether within or outside Company,
without prior written approval of Company. The Grantee shall take all reasonable steps necessary to ensure that confidentiality
is maintained by any of the individuals or entities referenced above to whom disclosure is authorized.

 

    	 	Terms and Conditions - Page 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00274-of-00352.parquet"}]]